Skip to main content

Table 1 Characteristics of patients included in the derivation and validation CBP cohorts

From: A universal predictive and mechanistic urinary peptide signature in acute kidney injury

Parameters CBP cohort

Derivation (n = 509)

Validation (n = 661)

Adjusted univariate p value

Preoperative features

Male, n (%)

381 (74.9)

501 (75.8)

0.836

Age (years), mean ± SD

67.6 ± 11.4

66.1 ± 12.4

0.071

BMI (kg/m2), mean ± SD

26.9 ± 4.4

26.8 ± 4.7

0.811

Diabetes, n (%)

127 (25)

179 (27.1)

0.571

Hypertension, n (%)

269 (52.8)

399 (60.4)

0.029

PAOD, n (%)

49 (9.6)

59 (8.9)

0.836

Stroke, n (%)

33 (6.5)

57 (8.6)

0.312

COPD, n (%)

29 (5.7)

97 (14.7)

 < 0.001

EuroSCORE-II, mean ± SD

2.4 ± 2.6

2.7 ± 4.3

0.150

LVEF (%), mean ± SD

55.9 ± 11.3

56.1 ± 11

0.844

Serum Creatinine (μmol/L), mean ± SD

98.3 ± 41.2

88.3 ± 30.1

 < 0.001

eGFR (mL/min.1.73m2), mean ± SD

70.3 ± 20.2

77.6 ± 20.6

 < 0.001

Kidney graft recipients, n (%)

7 (1.4)

6 (0.9)

0.771

Per-operative features

Surgery

   

 CAB, n (%)

196 (38.5)

245 (37.1)

 

 Valvular, n (%)

175 (34.4)

199 (30.1)

0.220

 Combined, n (%)

71 (13.9)

105 (15.9)

 

 Thoracic aorta, n (%)

58 (11.4)

87 (13.2)

 

 Myocardium, n (%)

9 (1.8)

25 (3.8)

 

Previous cardiac surgery, n (%)

23 (4.5)

57 (8.6)

0.022

CBP time (min), mean ± SD

85.3 ± 36.2

88.5 ± 36.5

0.246

RBC transfusion, n (%)

91 (17.9)

59 (8.9)

 < 0.001

 Number, mean ± SD

0.4 ± 0.9

0.2 ± 0.8

0.001

Vasoactive agents, n (%)

456 (89.6)

627 (94.9)

0.003

Postoperative features

RBC transfusion, n (%)

151 (29.7)

155 (23.4)

0.045

 Number, mean ± SD

0.8 ± 1.8

0.7 ± 1.9

0.368

Vasoactive agents, n (%)

277 (54.4)

445 (67.3)

 < 0.001

 Duration (day), mean ± SD

1.2 ± 2.1

1.6 ± 2.6

0.004

Infection, n (%)

83 (16.3)

112 (16.9)

0.858

Iodinated contrast agents, n (%)

25 (4.9)

7 (1.1)

0.001

Mechanical ventilation duration (d), mean ± SD

19.5 ± 77.2

12.4 ± 42.6

0.122

ICU stay duration (day), mean ± SD

5.6 ± 6.7

4.2 ± 5.2

 < 0.001

Outcomes

AKI KDIGO

   

 0, n (%)

389 (76.4)

486 (73.5)

 

 1, n (%)

78 (15.3)

82 (12.4)

0.005

 2, n (%)

23 (4.5)

69 (10.4)

 

 3, n (%)

19 (3.7)

24 (3.6)

 

In-hospital mortality, n (%)

15 (2.9)

26 (3.9)

0.571

  1. This table presents the clinical characteristics and outcome of all CBP patients irrespective of the availability of a urine sample.
  2. BMI Body mass index, PAOD Peripheral artery obliterans disease, COPD Chronic obstructive pulmonary disease, LVEF Left ventricular ejection fraction, eGFR Estimated glomerular filtration rate, CBP Cardiac bypass, RBC Red blood cells, SD Standard deviation, AKI Acute kidney injury, KDIGO Kidney disease/improving global outcome classification